FocalTherics to Present at H.C. Wainwright Conference

FocalTherics™, a global leader in robotic focal therapy, is set to participate in the H.C. Wainwright 28th Annual Global Investment Conference, to be held in New York from September 14-16, 2026. The company's CEO, Ryan Rhodes, will deliver a presentation on Tuesday, September 15, at 10:30 AM Eastern Time. Rhodes will be joined by Chief Financial Officer Ken Mobeck to host one-on-one investor meetings on both Tuesday and Wednesday of the conference.

The live and archived webcast of the presentation will be available on the Investors section of FocalTherics' website. Interested parties can access it through the following link: <https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59>.

FocalTherics is known for its innovative approach to medical treatments, particularly through its flagship platform, Focal One® Robotic HIFU. This technology combines advanced imaging, real-time treatment planning, robotic precision, and high-intensity focused ultrasound (HIFU) to provide personalized, minimally invasive therapy. The company focuses on treating various conditions while ensuring the highest possible quality of life for patients.

As a leader in the field, FocalTherics continues to advance its robotic focal therapy solutions, aiming to provide cutting-edge medical treatments to a global audience. The company's presence at the H.C. Wainwright conference underscores its commitment to engaging with investors and sharing its progress and future plans.